ABSTRACT: Several lines of e\adence indicate that GABA and neuropeptide Y (NPY) are functionally coupled and may interact in the regulation of fear-and anxiety-induced behavior. Neuroanatomical studies demonstrated that GABA and NPY coexist in neurons of the amygdaloid complex and that NPY may directly modulate the activity' of GABAergic neurons by stimulating Yi receptors. By using a transgenic mouse model harboring a construct comprising the murine Yi receptor gene promoter fused to a lacZ reporter gene {YiR/LacZ mice), we showed that long-term treatment with positive (diazepam or abecamil) or negative {FG7142) modulators of GABAA receptor function induced a marked increase or decrease, respectively, in Yi receptor gene expression in the amygdala. Furthermore, we demonstrated that a sustained increase in the brain concentrations of neuroactive steroids, induced by pharmacological treatment or by physiological conditions such as pregnancy, increases Yi receptor gene expression in the amygdala of YiR/LacZ transgenic mice, an effect similar to that induced by diazepam or abecarnil. These data provide evidence of a functional interaction between GABAergic and NPY-Yi mediated transmission and suggest that neuroactive steroids may play an important role in the regulation of the NPY transmission. Fmally, our data support a role of Yj receptors in the beha\'ioral and neuroendocrine responses to stress that, however, appears to be independent on the activation of the GABAergic system.
L INTRODUCTION
NPY is a 36 aminoacid neuropeptide playing an important role in the control of various physiological processes, including suppression of fear-and anxiety-induced behavior.^ The pharmacological administration of NPY into the CNS induces anxiolytic effects in various animal models, similar to those induced by positive modulators of GABAA receptor complex. TKe anxiolytic effect of NPY appears to be mediated by activation of the Yi receptor subtype in the amygdala.^ Various lines of evidence suggest the existence of a functional coupling between GABAA and NPY-Yi receptors that can be important in the anxiolytic, sedative, anticonvulsant, and food intake behavioral effects of benzodiazepines."'"Î n rodents, a marked plasticity in the expression of the Yi receptor and its mRNA in the CNS can be induced by different circumstances. For instance, electrical kindling and kainic acid-induced epilepsy decrease Yi receptor and Yi receptor mRNA in rat hippocampus/"^ In the arcuate nucleus food deprivation decreases, and hyperfagia increases, Yi receptor gene expression.^""^" Thus, compensatory changes in Yi receptor gene expression may reflect parallel changes in the functional activity of NPY-Yi receptor mediated neurotransmission.
We have generated transgenic mouse lines carrying the 1.3 Kb 5' flanking region of the mouse Yi receptor promoter fused to the coding region of the Escherichia coli LacZ gene {YiR/LacZ mice).^^ This construct contains sufficient information to replicate the expression pattern of the endogenous Yi receptor gene in a CNS-restricted and developmental stagespecific manner, although differences in the relative levels of the expression of the endogenous gene and the native protein could be seen."^T his review summarizes the experiments performed in our laboratories during the last few years to study the functional interaction between GABAergic and NPY-Yi mediated transmission in the YiR/LacZ transgenic mice model. In particular, we investigated the effect ot treatment vnth positive or negative allosteric modulators of the GABAA receptor complex and of the exposure to various stress paradigms, on the Yi receptor function in the amygdala using YiR/ LacZ transgene expression as a marker of altered signal transduction. Changes in transgene expression were measured by computer-assisted quantitative analysis of p-galactosidase histochemical staining in the medial and central nuclei of the amygdala, a structure that is important for fear and anxiet\' in both experimental animals and humans.^^"^^Transgene expression was evaluated in parallel in the medial habenula, because this brain region expresses high levels of p-galactosidase-positive cells but is not involved in the regulation of anxiety behavior.
II. NEUROANATOMICAL BASIS FOR FUNCTIONAL INTERACTION BETWEEN GABAERGIC AND NPY Yi SYSTEMS IN MEDIAL AMYGDALA
NPY has frequently been observed in GABAergic neurons in the cerebral cortex, basolateral amygdala, hippocampus, and hypothalamus.^^"^^ Using immunolabeling for NPY and GABA and histochemical staining ofYiR/LacZ transgene expression, we extended these studies and provided morphological evidence in support of a possible interplay between GABA-and NPY-Yi-mediated transmission in the medial amygdala.^^ Through confocal analysis of sections treated for the simultaneous detection of p-galactosidase staining, GABA and NPY revealed a high degree of colocalization for GABA or NPY and the YjR/LacZ transgene (Fig. l) .'Ihe majority of NPY-IR cell bodies were positive for GABA, and in some cases \ve observed the coexistence of GABA and NPY within the same nerve fibers. GABAergic neurons showing the YjR/LacZ transgene expression were usually in close contact wdth NPY-IR fibers that were surrounding or covering the cell bodies. These data suggest that a network of axons from NPY neurons innervate GABAergic neurons that also express the Yi receptor gene and that NPY might inhibit GABA release by the activation of this receptor subtype. On the other hand, several GABA-producing neurons, which are surrounded by NPY-positive fibers, did not display p-galactosidase positive staining, indicating that not all GABAergic neurons are regulated by Yi receptors. Moreover, few NPY-IR cell bodies also showed the (3-galactosidase histochemical activity suggesting a possible role of the Yi receptor as an auto-receptor regulating the NPY release in this brain area. These findings could account for a complex response to NPY in the medial amygdala and suggest that the interconnectivity between the NPY-Yi-mediated transmission and the GABAergic system may be an important regulatory mechanism within the medial amygdala and may contribute to NPY's effects on anxious behavior.
III. CHRONIC MODULATION OF GABAA RECEPTORS REGULATE YiR GENE EXPRESSION IN AMYGDALA OF YiR/LACZ TRANSGENIC MICE

Effect of Benzodiazepines and p-Carfao//nes
Positive allosteric modulators of GABA-gated Cl~ channels, such as diazepam, enhance GABAergic transmission and produce both anxiolytic and anticonvulsant effects on behavior.^^^"^ Conversely, negative allosteric modulators of the GABAA receptor complex, such as the p-carboline FG 7142, inhibit GABAA receptor function and elicit anxiogenic and proconvulsant activity. On chronic treatment, the administration of diazepam and other agonists of the benzodiazepine binding site decreases GABAA receptor function, whereas repeated administration of FG7142 produces an increase in sensitivity to its proconvulsant activity.^^'^^ Furthermore, chronic exposure to diazepam and FG 7142 alters the expression of GABAA receptor subunits mRNA in a different manner.^B y using the Y^R/LacZ transgenic model, we demonstrated that chronic treatment with positive modulators of GABAA receptor significantly increases, and inverse agonists decrease, p-galactosidase expression in the medial amygdala ofYiR/LacZ transgenic mice but not in the medial habenula, analyzed as a control region.^^ These findings indicate that altered GABAA receptor function may also induce changes in Yi receptor gene expression and provide functional evidence that the NPY-Yi receptor-mediated transmission and GABAergic system are closely coupled within the amygdala and may interact in the regulation of anxiety behavior. The prolonged administration of positive and negative allosteric modulators of the GABA receptor complex may possibly induce compensatory changes in the activity of the GABA-and NPY-containing neurons and, in turn, in Yi receptor gene expression. Clinical and experimental evidence indicates that long-term treatment with various benzodiazepines results in the development of tolerance and dependence.^^ TKese pharmacological phenomena are paralleled by an alteration in the sensitivity of GABAergic synapses that is associated vnth compensatory changes in the expression of GABAA receptor subunit genes.^'' Changes in YjR/LacZ transgene expression were observed only after a chronic treatment with diazepam because the acute treatment with this drug failed to affect transgene expression. However, because the long-term administration of abecarnil, an anxiolytic and anticonvulsant p-carboline derivative that does not induce physical dependence,^' induces effects similar to those of diazepam, the compensator}' changes on NPY-Yi neurotransmission are unlikely to account for diazepam dependence and tolerance.
Effect of neuroactive steroids
The progesterone and the deoxycorticosterone derivatives (allopregnanolone/AP and allotretrahydrodeoxycorticosterone/THDOC) are endogenous neuroactive steroids, synthesized in the CNS, that constitute an interesting set of pharmacological agents endowed with Critica/Reviews™ in Neurobiology neuromodulatory actions.These molecules potentiate the GABAA receptor function and elicit anxiolytic, anticonvulsant, and hypnotic/anesthetic effects similar to those produced by other positive allosteric modulators of GABAA receptors (for a review, see [30] [31] . In particular, the anxiolytic action of AP has been demonstrated in various animal models of anxiety, and the amygdaloid complex has recently been implicated as a brain region that plays an important role in mediating the anxiolytic action of AP.^F luctuations in the brain concentrations of AP and THDOC, occurring in association with specific physiological conditions such as pregnancy and delivery, result in changes in neuronal excitability and, in turn, in alteration of emotional state, sleep pauern, and seizure threshold.^^'^^ At the molecular level, such effects are associated with changes in the efficacy of GABA and of allosteric modulators {benzodiazepines and AP) at the GABAA receptor as well as with changes in the expression of GABAA receptor subunits.^Ĝ iven that AP and THDOC are among the most potent positive modulators of GABAA receptor function known, long-lasting changes in the brain concentrations of these neuroactive steroids also might be expected to affect Yi receptor expression in the amygdala. We showed that chronic treatment with progesterone or with AP, a 5a-reduced metabolite of progesterone, significantly elevates the cerebrocortical concentration of AP and induces an increase in the expression of the YjR/LacZ transgene in the medial amygdala similar to that elicited by long-term administration of abecarnil or diazepam.^''
In addition, physiological fluctuations in the brain concentrations of endogenous AP and THDOC during pregnancy are also associated with an increase in YiR/LacZgene expression in the medial amygdala."*T he levels ot Yi receptor mRNA in the medial amygdala were also increased on day 18 of pregnancy, suggesting that changes in transgene expression reflect parallel changes in the endogenous Yi receptor gene that are achieved, at least in part, via transcriptional mechanisms (Fig. 2) .
The increase in the Yi receptor gene expression in the medial amygdala induced by chronic treatment with progesterone or by physiological conditions such as pregnancy is likely to be mediated by AP and THDOC through their selective action at the GABAA receptor, because the administration of finasteride, a selective blocker of metabolic conversion of progesterone by 5a-reductase,''^ prevented both the accumulation of AP and THDOC in the cerebral cortex as well as the increase in YiR/LacZ gene expression in the amygdala. In addition to preventing the progesterone-induced increase in YiR/LacZ transgene expression, finasteride inhibits changes in the expression of GABAA receptor subunit genes elicited by this hormone."^Ô ur finding therefore suggests that the high concentrations achieved by neurosteroids in the cerebral cortex of mice during pregnancy might play a major role in modulation of both GABAA and Yi receptor gene expression. Indeed, the reduction in the brain concentrations of these steroids elicited either by a physiological condition (delivery) or by pharmacological treatment (finasteride) reversed or prevented the pregnancy-associated changes in both systems.
Discontinuation of chronic progesterone administration as well as the rapid decrease in the progesterone plasma concentrations following delivery induce withdrawal effects at the behavioral and molecular levels that are highly similar to those elicited by discontinuation of long-term treatment with GABAA receptor-modulatory drugs such as benzodiazepines.^*'The YiR/LacZ transgene expression increase in the medial amygdala was no longer apparent 24 hours after the last hormone injection, or after delivery indicating that changes in Yi receptor-mediated neurotransmission do not play a role in progesterone-induced withdrawal syndrome. This is in line with the observation that the long- 
III. RESTRAINT STRESS INCREASES EXPRESSION OF NPY-YI RECEPTOR GENE IN AMYGDALA OF YiR/lACZ TRANSGENIC MICE
NPY and GABA may also interact to inhibit the excitatory effects of CRP in the annygdala and thereby contribute to the overall response to stressful or threatening stimuli. Short-term physical restraint, which induces anxiety, reduces NPY mRNA and protein concentrations in the amygdala and cortex of rats.*Î n contrast, repeated exposure to restraint once daily for 10 days increases NPY expression in the amygdala and in the arcuate nucleus.*Ŝ everal acute stress paradigms, such as forced swimming, foot shock, and carbon dioxide inhalation, reduce GABAA receptor function in several brain regions, induce proconflict behavior,"*^ and increase the concentrations of neuroactive steroids in plasma and brain to levels that are high enough to activate GABAA receptors.'*"' The rapid and persistent increase in neuroactive steroid concentrations induced by acute stress has been proposed to represent a homeostatic mechanism for the restoration of GABAA receptor function and to be physiologically relevant in protection against stress-induced seizures.
Given that the high levels of neuroactive steroids achieved in the brain during pregnancy or long-term administration of progesterone affect both GABAA receptor and Yi receptor gene expression,'^^'"'^ we have examined the hypothesis that fluctuations in the plasma and brain content of these compounds also might participate in the regulation ofYi receptor plasticit)' in response to restraint stress.
A single 1-hour episode of restraint induced a transient increase in the cerebrocortical concentrations of neuroactive steroids that returned to control values within 30 minutes. Acute exposure to restraint also increased YiR/LacZ transgene expression in the central and in the medial amygdala of transgenic mice."^ Finasteride prevented the transient increase in the cerebrocortical concentrations of AP and THDOC, but failed to inhibit that in Yi receptor gene expression in the amygdala of the stressed animals. These observations suggest that the increase in Y) receptor gene expression induced by acute stress is not mediated by the short-term increase in the brain levels of AP and THDOC; rather, the increase in Yi receptor gene expression induced by acute restraint may be triggered by the stress-induced reduction in functional NPY transmission in the amygdala and likely reflects ligand-induced regulation ofYi receptor gene transcription.
Our observation that repeated restraint (one 1-hour episode per day for 10 days), which induced repetitive and transient increases in the cerebrocortical concentrations of neuroactive steroids, failed to affect the extent of histochemical staining for p-galactosidase activity in the amygdala of YiR/LacZ mice, further suggests that a sustained increase in the brain concentrations of these steroids is required for modulation of Yi receptor gene expression.
V. CONCLUSIONS
We provided morphological and Rinctional evidence for an interaction between GABA and NPY in the amygdaloid complex that may play an important role in regulation of the effects of NPY on anxiety-like behavior. In particular, we have shown that the sustained increase in the brain concentrations of endogenous neuroactive steroids during pregnancy is associated with an increase of Yi receptor gene transcription and expression, and that these changes are reversed by delivery or prevented by finasteride, both of which markedly reduce the brain levels of these hormones. Given that GABAA receptor gene expression is similarly modulated, our data suggest that the secretion of neuroactive steroids is an important physiological determinant of GABAergic and NPY-Yi transmission, both of which contribute to the modulation of emotional behavior. The large fluctuations in the brain concentrations of neuroactive steroids that occur during certain physiological conditions, such as pregnancy and menopause, therefore might exert an important homeostatic action by modulating the plasticity of both GABAA receptor-mediated and NPY-Yi neurotransmission in the amygdala in order to counteract the changes in neuronal excitability and the anxiety-like behavior also associated with such conditions. 
